(Q46188988)

20 December 2017

meta-analysis

0 references

title

Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism (English)

1 reference

20 December 2017

1 reference

1 reference

1 reference

David Keith Cundiff

1

1 reference

20 December 2017

publication date

11 November 2008

1 reference

20 December 2017

Medscape journal of medicine

published in

1 reference

20 December 2017

volume

10

1 reference

20 December 2017

issue

11

1 reference

20 December 2017

page(s)

258

1 reference

20 December 2017

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

cites work

1 reference

12 December 2020

Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial

1 reference

12 December 2020

Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial

1 reference

12 December 2020

D-dimer testing to determine the duration of anticoagulation therapy

1 reference

12 December 2020

Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer

1 reference

12 December 2020

Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial

1 reference

12 December 2020

Idraparinux versus standard therapy for venous thromboembolic disease

1 reference

12 December 2020

Extended prophylaxis of venous thromboembolism with idraparinux.

1 reference

12 December 2020

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome

1 reference

12 December 2020

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis

1 reference

12 December 2020

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators

1 reference

12 December 2020

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

12 December 2020

Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

1 reference

12 December 2020

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

1 reference

12 December 2020

Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor

1 reference

12 December 2020

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Effect of cessation of anticoagulant therapy on the course of ischaemic heart disease

1 reference

12 December 2020

Relapses of thromboembolic disease after discontinued anticoagulant therapy. A comparison of the incidence after abrupt and after gradual termination of treatment

1 reference

12 December 2020

Treatment of deep-vein thrombosis--a random trial

1 reference

12 December 2020

The duration of oral anticoagulation after deep vein thrombosis. A randomized study

1 reference

12 December 2020

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

1 reference

12 December 2020

One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis.

1 reference

12 December 2020

A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism

1 reference

12 December 2020

[Value of anticoagulant therapy in deep venous thrombosis in the lower limb in elderly, mobilized patients. A double-blind placebo controlled study with open therapeutic guidance]

1 reference

12 December 2020

Aspirin, heparin, or both to treat acute unstable angina

1 reference

12 December 2020

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group

1 reference

12 December 2020

Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients

1 reference

12 December 2020

Reactivation of unstable angina after the discontinuation of heparin

1 reference

12 December 2020

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

1 reference

12 December 2020

Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation.

1 reference

12 December 2020

Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants--a prospective study

1 reference

12 December 2020

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes

1 reference

12 December 2020

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

1 reference

12 December 2020

Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

1 reference

12 December 2020

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

1 reference

12 December 2020

Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double-blind randomized study

1 reference

12 December 2020

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

1 reference

12 December 2020

Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation

1 reference

12 December 2020

The risk of interrupting long-term anticoagulant treatment. A rebound hypercoagulable state following hemorrhage

1 reference

12 December 2020

Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatran

1 reference

12 December 2020

Identifiers

1 reference

20 December 2017